Register entry
- Registered sites
- 1
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 1
- Base
- Belgium
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| argenx BV | Industriepark Zwijnaarde 7, Gent, 9052, Belgium (BEL) | Finished drug manufacture | 3015102398400523378 |
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: BLA 3.
| Dosage form | NDCs |
|---|---|
| injection, solution | 2 |
| injection | 1 |
| Route | NDCs |
|---|---|
| subcutaneous | 2 |
| intravenous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| argenx us | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| VYVGART | EFGARTIGIMOD ALFA | injection, intravenous | 73475-3041BLA |
| VYVGART Hytrulo | efgartigimod alfa and hyaluronidase (human recombinant) | injection, solution, subcutaneous | 73475-1221BLA |
| VYVGART Hytrulo | efgartigimod alfa and hyaluronidase (human recombinant) | injection, solution, subcutaneous | 73475-3102BLA |
Compare
Comparable companies in Belgium
- Henogen1 site · 1 NDC
- Purna Pharmaceuticals NV1 site · 1 NDC
- UCB, Inc.2 sites · 65 NDC
Enquiry
Common questions
- Is argenx BV FDA approved?
- argenx BV holds 1 FDA-registered establishment in Belgium. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are argenx BV's drugs manufactured?
- The FDA register lists Gent. Registered operations: finished drug manufacture.
- What drugs does argenx BV make?
- 3 products are listed under argenx BV in the openFDA NDC Directory, most often as injection, solution; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.